Pennsylvania plans to distribute more than 3.8 million Abbott BinaxNOW antigen rapid tests allocated to the state by the federal government. These tests, which have been arriving in weekly allotments since October and will continue through the end of December, are being used to test and protect vulnerable populations in Pennsylvania counties demonstrating substantial risk for community spread, prioritizing counties with outbreaks.
“It is a top priority to ensure that all people in Pennsylvania who need a test will have access to one,” said Michael Huff, director of testing and contact tracing for the state. “We will continue to closely monitor the number of cases in communities across the commonwealth to ensure that testing sites are situated appropriately in areas with the greatest need.”
The commonwealth is utilizing existing public health infrastructure to implement a prioritized, tiered approach to comprehensive testing throughout Pennsylvania. This public health network covers the entire state, with over 550 contracted sites and over 400 public health sites. A map can be found here.
